Research Assistant Professor, Department of Biomedical Sciences
Contact Information
Email:Biosketch
Anna Langerveld, PhD, is President and CEO of Genemarkers LLC, a company that provides collaborative services that enhance the utilization of genomics for improving health care, pharmaceutical research and consumer products. Dr. Langerveld is a graduate of SUNY - Binghamton in Binghamton, New York. She earned her doctorate in neuroscience from Tulane University in New Orleans, Louisiana.
Dr. Langerveld is an active researcher and presenter in the field of genomics. Her company has worked in conjunction with other companies applying genomics to the fields of animal health, personal care products, and molecular diagnostics.
Dr. Langerveld serves on the advisory board of the pharmacogenomics program of Manchester University, the first program to offer a one-year master's degree in pharmacogenomics.
-
Education and Training
- PhD 1998, Neuroscience, Tulane University
- BA 1989, Biochemistry, State University of New York at Binghamton
-
Research
- Neuroscience
-
Publications
DeHaven C., Wheeler S., Langerveld A., Johns C.B. Regulation of dermal circadian pathways by a novel topical formulation International Journal of Cosmetic Science. 2025;47:123-133.
Bright D.R., Klepser D., Langerveld A. Asynchronous consult report generation for pharmacogenomic clinical support: Time and motion Research in Social and Administrative Pharmacy. 2024;20:152-155.
Beam T.A., Klepser D.G., Klepser M.E., Bright D.R., Klepser N., Schuring H., Wheeler S., Langerveld A. COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice Research in Social and Administrative Pharmacy. 2023;19:1360-1364.
Kala R., Heiberger N., Mallin H., Wheeler S., Langerveld A. Reproducible method for assessing the effects of blue light using in vitro human skin tissues International Journal of Cosmetic Science. 2023;45:95-107.
Bright D., Langerveld A., DeVuyst-Miller S., Saadeh C., Choker A., Lehigh E., Wheeler S., Zayzafoon A., Sohn M. Identification of a sex-stratified genetic algorithm for opioid addiction risk Pharmacogenomics Journal. 2021;21:326-335.
Bright D., Saadeh C., Devuyst-Miller S., Sohn M., Choker A., Langerveld A. Pharmacist consult reports to support pharmacogenomics report interpretation Pharmacogenomics and Personalized Medicine. 2020;13:719-724.
Bright D.R., Greco A.J., Langerveld A., Kisor D.F. Clinical implementation of personalized medicine in community pharmacies: Considerations for clinicians Personalized Medicine. 2017;14(6):471-475.
Langerveld A., Schnarr P., Suarez M., Jarrett J.C., Conaghan J., Rosa G.J.M., Fernández E., Rawlins R.G., Cibelli J.B., Crosby J.A. Identification of a novel gene set in human cumulus cells predictive of an oocyte's pregnancy potential Fertility and Sterility. 2013;99(3)
Langerveld A.J., Celestine R., Zaya R., Mihalko D., Ide C.F. Chronic exposure to high levels of atrazine alters expression of genes that regulate immune and growth-related functions in developing Xenopus laevis tadpoles Environmental Research. 2009;109(4):379-389.
Langerveld A., Mihalko D., DeLong C., Walburn J., Ide C.F. Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients Movement Disorders. 2007;22(6):766-777.
Katbamna B., Langerveld A., Ide C.F. Aroclor 1254 impairs the hearing ability of Xenopus laevis Journal of Comparative Physiology A: Neuroethology, Sensory, Neural, and Behavioral Physiology. 2006;192(9):971-983.
Lehigh Shirey E., Jelaso Langerveld A., Mihalko D., Ide C. Polychlorinated biphenyl exposure delays metamorphosis and alters thyroid hormone system gene expression in developing Xenopus laevis Environmental Research. 2006;102(2):205-214.